BOARD AND COMMITTEE MEMBERSHIPS
2012 - Present
ACRO Economics Committee
2012 - Present
Founding Member, ACRO New Practitioner Development Committee
2012 - 2013
Chairman, Covenant Health System Cancer Committee
2014 - Present
Houston Northwest Medical Center Cancer Committee
2014 - Present
Medical Director, Division of Radiation Oncology, CSNF
2016 - Present
ASTRO Code Development and Valuation Subcommittee
2012 - Present
Mentor, ACRO Resident Mentorship Program
2010 - 2011
Ex-Officio Member, ACRO National Resident Executive Committee
2009 - 2010
Columbia University ACR Task Force
2009 - Present
ASTRO Code Utilization and Application Committee
2009 - 2011
Administrator and Moderator, ACRO Residents Forum
2009 - 2010
ACRO Legislative Affairs Committee
2009 - 2010
Chief Resident, Columbia University Department of Radiation Oncology
2008 - 2010
ACRO National Resident Executive Committee
2008 - 2010
New York Presbyterian Quality Council
2003 - 2005
President, Oncology Interest Group, Northeast Ohio Medical Univ
2003 - 2005
Student Academic Mentor, Northeast Ohio Medical Univ.
RESEARCH
2009 - 2010
Oncology Translational Research: Columbia University College of Physicians and Surgeons
2009 - 2010
Oncology Basic Science Research: Columbia University College of Physicians and Surgeons
Principal Investigator Responsibilities
NCT03237325
A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and neck. Phase N/A, Interventional
NCT02141438
Radium-223 alpha Emitter Agent in Safety Study in mCRPC popUlation for long-teRm Evaluation . Phase N/A, Observational
PUBLICATIONS
Brachytherapy
“Long Term Results Including Mastectomy Rates of Accelerated Partial Breast Brachytherapy Treatment at a Single Institution.”
Radiotherapy and Oncology
“Interstitial High Dose Rate (HDR) Brachytherapy for Ductal Carcinoma In Situ of the Breast: Median 6 year Results of 66 Cases Using Multi-catheter Technique.”
Oncology
“Deletion of the Betaig-h3 Gene Confers Multi-agent Chemoresistance in a Non-Small Cell Lung Cancer Cell Line.”
American Journal of Clinical Oncology
“Pathologic Analysis of CT and Ultrasound Imaging Accuracy for Prostate Radiation Therapy.”
International Journal of Radiation Oncology, Biology, Physics
“Automated and Objective Assessments of Radiation-Induced Fibrosis Using Advanced Ultrasound Imaging in Breast Cancer Radiation Therapy.”
Medical Physics
“A Comparative Analysis of In Vivo and Ex Vivo Prostate Volumes Using CT and Ultrasound imaging.”
International Journal of Radiation Oncology, Biology, Physics
“The Predictive Value of 2-year Posttreatment Biopsy after Prostate Cancer Radiotherapy for Eventual Biochemical Outcome.”
Brachytherapy
“Biochemical Disease-Free Survival Rates Following Definitive Low-Dose-Rate Prostate Brachytherapy with Dose Escalation to Biologic Target Volumes Identified with SPECT/CT Capromab Pendetide.”
International Journal of Radiation Oncology, Biology, Physics
“Phase I/II Fractionated Stereotactic Radiotherapy and Weekly Paclitaxel in Malignant Gliomas.”
International Journal of Radiation Oncology, Biology, Physics
“Assessing the Utility of a 2-year Post Treatment Biopsy for Forecasting Eventual Biochemical Failure and Survival.”
Proceedings of American Society of Clinical Oncology
“Higher Dose of Paclitaxel is Needed For Patients on Phenytoin: Pharmacokinetics Study in Patients With Malignant Gliomas.”